Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Influenza Virus | Research article

Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009–2017

Authors: Hebah A. Al Khatib, Asmaa A. Al Thani, Imed Gallouzi, Hadi M. Yassine

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Influenza surveillance is necessary for detection of emerging variants of epidemiologic and clinical significance. This study describes the epidemiology of influenza types A and B, and molecular characteristics of surface glycoproteins (hemagglutinin [HA] and neuraminidase [NA]) of influenza A subtypes: pH1N1 and H3N2 circulated in Arabian Gulf, Levant and North Africa regions during 2009–2017.

Methods

Analysis of phylogenetics and evolution of HA and NA genes was done using full HA and NA sequences (n = 1229) downloaded from Influenza Research Database (IRD).

Results

In total, 130,354 influenza positive cases were reported to WHO during study period. Of these, 50.8% were pH1N1 positive, 15.9% were H3N2 positives and 17.2% were influenza B positive. With few exceptions, all three regions were showing the typical seasonal influenza peak similar to that reported in Northern hemisphere (December–March). However, influenza activity started earlier (October) in both Gulf and North Africa while commenced later during November in Levant countries. The molecular analysis of the HA genes (influenza A subtypes) revealed similar mutations to those reported worldwide. Generally, amino acid substitutions were most frequently found in head domain in H1N1 pandemic viruses, while localized mainly in the stem region in H3N2 viruses. Expectedly, seasons with high pH1N1 influenza activity was associated with a relatively higher number of substitutions in the head domain of the HA in pH1N1 subtype. Furthermore, nucleotide variations were lower at the antigenic sites of pH1N1 viruses compared to H3N2 viruses, which experienced higher variability at the antigenic sites, reflecting the increased immunological pressure because of longer circulation and continuous vaccine changes. Analysis of NA gene of pH1N1 viruses revealed sporadic detections of oseltamivir-resistance mutation, H275Y, in 4% of reported sequences, however, none of NAI resistance mutations were found in the NA of H3N2 viruses.

Conclusions

Molecular characterization of H1N1 and H3N2 viruses over 9 years revealed significant differences with regard to position and function of characterized substitutions. While pH1N1 virus substitutions were mainly found in HA head domain, H3N2 virus substitutions were mostly found in HA stem domain. Additionally, more fixed substitutions were encountered in H3N2 virus compared to larger number of non-fixed substitutions in pH1N1.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hay AJ, et al. The evolution of human influenza viruses. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356(1416):1861–70.CrossRef Hay AJ, et al. The evolution of human influenza viruses. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356(1416):1861–70.CrossRef
3.
go back to reference Molinari NA, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96.CrossRef Molinari NA, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96.CrossRef
4.
go back to reference Schafer JR, et al. Origin of the pandemic 1957 H2 influenza a virus and the persistence of its possible progenitors in the avian reservoir. Virology. 1993;194(2):781–8.CrossRef Schafer JR, et al. Origin of the pandemic 1957 H2 influenza a virus and the persistence of its possible progenitors in the avian reservoir. Virology. 1993;194(2):781–8.CrossRef
6.
go back to reference Cohen, J. and M. Enserink, Swine flu. After delays, WHO agrees: the 2009 pandemic has begun, in Science. 2009: United States. p. 1496–1497.CrossRef Cohen, J. and M. Enserink, Swine flu. After delays, WHO agrees: the 2009 pandemic has begun, in Science. 2009: United States. p. 1496–1497.CrossRef
7.
go back to reference Cohen AL, et al. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014;20(7):1162–9.CrossRef Cohen AL, et al. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014;20(7):1162–9.CrossRef
8.
go back to reference Martinez O, Tsibane T, Basler CF. Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol. 2009;28(1):69–92.CrossRef Martinez O, Tsibane T, Basler CF. Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol. 2009;28(1):69–92.CrossRef
9.
go back to reference Gerhard W, et al. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981;290(5808):713–7.CrossRef Gerhard W, et al. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981;290(5808):713–7.CrossRef
10.
go back to reference Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem. 1987;56:365–94.CrossRef Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem. 1987;56:365–94.CrossRef
11.
go back to reference Igarashi M, et al. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One. 2010;5(1):e8553.CrossRef Igarashi M, et al. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One. 2010;5(1):e8553.CrossRef
12.
go back to reference Gallagher P, et al. Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J Cell Biol. 1988;107(6 Pt 1):2059–73.CrossRef Gallagher P, et al. Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J Cell Biol. 1988;107(6 Pt 1):2059–73.CrossRef
13.
go back to reference Sun S, et al. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses. PLoS One. 2012;7(2):e32119.CrossRef Sun S, et al. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses. PLoS One. 2012;7(2):e32119.CrossRef
15.
go back to reference Chen Z, Zhou H, Jin H. The impact of key amino acid substitutions in the hemagglutinin of influenza a (H3N2) viruses on vaccine production and antibody response. Vaccine. 2010;28(24):4079–85.CrossRef Chen Z, Zhou H, Jin H. The impact of key amino acid substitutions in the hemagglutinin of influenza a (H3N2) viruses on vaccine production and antibody response. Vaccine. 2010;28(24):4079–85.CrossRef
16.
go back to reference Koel BF, et al. Identification of amino acid substitutions supporting antigenic change of influenza a(H1N1)pdm09 viruses. J Virol. 2015;89(7):3763–75.CrossRef Koel BF, et al. Identification of amino acid substitutions supporting antigenic change of influenza a(H1N1)pdm09 viruses. J Virol. 2015;89(7):3763–75.CrossRef
17.
go back to reference Haq Z, Mahjour J, Khan W. Communicable diseases in the eastern Mediterranean region: prevention and control 2010-2011. East Mediterr Health J. 2013;19(10):888–91.CrossRef Haq Z, Mahjour J, Khan W. Communicable diseases in the eastern Mediterranean region: prevention and control 2010-2011. East Mediterr Health J. 2013;19(10):888–91.CrossRef
20.
go back to reference Buliva E, et al. Emerging and reemerging diseases in the World Health Organization (WHO) eastern Mediterranean region-Progress, challenges, and WHO initiatives. Front Public Health. 2017;5:276.CrossRef Buliva E, et al. Emerging and reemerging diseases in the World Health Organization (WHO) eastern Mediterranean region-Progress, challenges, and WHO initiatives. Front Public Health. 2017;5:276.CrossRef
21.
go back to reference Soebiyanto RP, et al. Associations between meteorological parameters and influenza activity in Berlin (Germany), Ljubljana (Slovenia), castile and Leon (Spain) and Israeli districts. PLoS One. 2015;10(8):e0134701.CrossRef Soebiyanto RP, et al. Associations between meteorological parameters and influenza activity in Berlin (Germany), Ljubljana (Slovenia), castile and Leon (Spain) and Israeli districts. PLoS One. 2015;10(8):e0134701.CrossRef
22.
go back to reference Khan W, et al. Influenza Research in the eastern Mediterranean region: a review. Oman Med J. 2017;32(5):359–64.CrossRef Khan W, et al. Influenza Research in the eastern Mediterranean region: a review. Oman Med J. 2017;32(5):359–64.CrossRef
23.
go back to reference Tamerius JD, et al. Environmental predictors of seasonal influenza epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e1003194.CrossRef Tamerius JD, et al. Environmental predictors of seasonal influenza epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e1003194.CrossRef
26.
go back to reference Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther. 2012;17(1 Pt B):159–73.CrossRef Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther. 2012;17(1 Pt B):159–73.CrossRef
27.
go back to reference Tamura K, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9.CrossRef Tamura K, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9.CrossRef
28.
go back to reference Yang H, Carney P, Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2010;2:Rrn1152.CrossRef Yang H, Carney P, Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2010;2:Rrn1152.CrossRef
29.
go back to reference Huang J-W, Yang J-M. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses; 2011.CrossRef Huang J-W, Yang J-M. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses; 2011.CrossRef
30.
go back to reference Choi Y, et al. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7(10):e46688.CrossRef Choi Y, et al. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7(10):e46688.CrossRef
31.
go back to reference Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214.CrossRef Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214.CrossRef
32.
go back to reference Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22(5):1208–22.CrossRef Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22(5):1208–22.CrossRef
34.
go back to reference Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med. 2006;3(4):e89.CrossRef Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med. 2006;3(4):e89.CrossRef
35.
go back to reference Tanarhte MHP, Lelieveld J. Intercomparison of temperature and precipitation data sets based on observations in the Mediterranean and the Middle East. J Geophysical Res. 2012:117. Tanarhte MHP, Lelieveld J. Intercomparison of temperature and precipitation data sets based on observations in the Mediterranean and the Middle East. J Geophysical Res. 2012:117.
36.
go back to reference World Health Organisation, Influenza Updat. 2009-2016, WHO. World Health Organisation, Influenza Updat. 2009-2016, WHO.
37.
go back to reference Chutinimitkul S, et al. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza a(H1N1) virus affects receptor binding. J Virol. 2010;84(22):11802–13.CrossRef Chutinimitkul S, et al. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza a(H1N1) virus affects receptor binding. J Virol. 2010;84(22):11802–13.CrossRef
38.
go back to reference Schulze IT. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis. 1997;176(Suppl 1):S24–8.CrossRef Schulze IT. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis. 1997;176(Suppl 1):S24–8.CrossRef
39.
go back to reference Sriwilaijaroen N, Suzuki Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226–49.CrossRef Sriwilaijaroen N, Suzuki Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226–49.CrossRef
40.
go back to reference Air GM. Influenza neuraminidase. Influenza Other Respir Viruses. 2012;6(4):245–56.CrossRef Air GM. Influenza neuraminidase. Influenza Other Respir Viruses. 2012;6(4):245–56.CrossRef
41.
go back to reference Maurer-Stroh S, et al. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza a virus. PLoS Curr. 2010;2:Rrn1162.CrossRef Maurer-Stroh S, et al. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza a virus. PLoS Curr. 2010;2:Rrn1162.CrossRef
42.
go back to reference Graham M, et al. Nationwide molecular surveillance of pandemic H1N1 influenza a virus genomes: Canada, 2009. PLoS One. 2011;6(1):e16087.CrossRef Graham M, et al. Nationwide molecular surveillance of pandemic H1N1 influenza a virus genomes: Canada, 2009. PLoS One. 2011;6(1):e16087.CrossRef
43.
go back to reference Liu SS, et al. Susceptibility of influenza a(H1N1)/pdm2009, seasonal a(H3N2) and B viruses to oseltamivir in Guangdong, China between 2009 and 2014. Sci Rep. 2017;7(1):8488.CrossRef Liu SS, et al. Susceptibility of influenza a(H1N1)/pdm2009, seasonal a(H3N2) and B viruses to oseltamivir in Guangdong, China between 2009 and 2014. Sci Rep. 2017;7(1):8488.CrossRef
44.
go back to reference Butler J, et al. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant a(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014;10(4):e1004065.CrossRef Butler J, et al. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant a(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014;10(4):e1004065.CrossRef
45.
go back to reference Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza a viruses from 1999 to 2006: a complete genome study. Virol J. 2008;5:40.CrossRef Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza a viruses from 1999 to 2006: a complete genome study. Virol J. 2008;5:40.CrossRef
46.
go back to reference Caini S, et al. Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010-2016: circulating influenza a and B viruses and spatial timing of epidemics. Influenza Other Respir Viruses. 2018;12(3):344–52.CrossRef Caini S, et al. Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010-2016: circulating influenza a and B viruses and spatial timing of epidemics. Influenza Other Respir Viruses. 2018;12(3):344–52.CrossRef
47.
go back to reference Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999;17(Suppl 1):S3–10.CrossRef Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999;17(Suppl 1):S3–10.CrossRef
48.
go back to reference Simonsen L, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53–60.CrossRef Simonsen L, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53–60.CrossRef
49.
go back to reference Bedford T, et al. Integrating influenza antigenic dynamics with molecular evolution. Elife. 2014;3:e01914.CrossRef Bedford T, et al. Integrating influenza antigenic dynamics with molecular evolution. Elife. 2014;3:e01914.CrossRef
50.
go back to reference Smith DJ, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371–6.CrossRef Smith DJ, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371–6.CrossRef
51.
go back to reference Klein EY, et al. Influenza a H1N1 pandemic strain evolution--divergence and the potential for antigenic drift variants. PLoS One. 2014;9(4):e93632.CrossRef Klein EY, et al. Influenza a H1N1 pandemic strain evolution--divergence and the potential for antigenic drift variants. PLoS One. 2014;9(4):e93632.CrossRef
52.
go back to reference CDC, Seasonal Influenza Vaccine Effectiveness, 2004-2018. 2004-2018, Centers for Disease Control and Prevention. CDC, Seasonal Influenza Vaccine Effectiveness, 2004-2018. 2004-2018, Centers for Disease Control and Prevention.
53.
go back to reference Liu Y, et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic a(H1N1) 2009 influenza virus. J Virol. 2010;84(22):12069–74.CrossRef Liu Y, et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic a(H1N1) 2009 influenza virus. J Virol. 2010;84(22):12069–74.CrossRef
54.
go back to reference Kilander A, et al. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza a(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010;15(9). Kilander A, et al. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza a(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010;15(9).
55.
go back to reference Gamblin SJ, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science. 2004;303(5665):1838–42.CrossRef Gamblin SJ, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science. 2004;303(5665):1838–42.CrossRef
56.
go back to reference Maines TR, et al. Transmission and pathogenesis of swine-origin 2009 a(H1N1) influenza viruses in ferrets and mice. Science. 2009;325(5939):484–7.CrossRef Maines TR, et al. Transmission and pathogenesis of swine-origin 2009 a(H1N1) influenza viruses in ferrets and mice. Science. 2009;325(5939):484–7.CrossRef
57.
go back to reference de Vries RP, et al. Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol. 2013;87(24):13868–77.CrossRef de Vries RP, et al. Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol. 2013;87(24):13868–77.CrossRef
58.
go back to reference Jayaraman A, et al. A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One. 2011;6(3):e17616.CrossRef Jayaraman A, et al. A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One. 2011;6(3):e17616.CrossRef
59.
go back to reference Luksza M, Lassig M. A predictive fitness model for influenza. Nature. 2014;507(7490):57–61.CrossRef Luksza M, Lassig M. A predictive fitness model for influenza. Nature. 2014;507(7490):57–61.CrossRef
60.
go back to reference Wei CJ, et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med. 2010;2(24):24ra21.CrossRef Wei CJ, et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med. 2010;2(24):24ra21.CrossRef
61.
go back to reference Ison MG. Antivirals and resistance: influenza virus. Curr Opin Virol. 2011;1(6):563–73.CrossRef Ison MG. Antivirals and resistance: influenza virus. Curr Opin Virol. 2011;1(6):563–73.CrossRef
62.
go back to reference Meijer A, et al. Oseltamivir-resistant influenza virus a (H1N1), Europe, 2007-08 season. Emerg Infect Dis. 2009;15(4):552–60.CrossRef Meijer A, et al. Oseltamivir-resistant influenza virus a (H1N1), Europe, 2007-08 season. Emerg Infect Dis. 2009;15(4):552–60.CrossRef
64.
go back to reference Lackenby, A., et al., Continued emergence and changing epidemiology of oseltamivir-resistant influenza a(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5). Lackenby, A., et al., Continued emergence and changing epidemiology of oseltamivir-resistant influenza a(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5).
65.
go back to reference Storms AD, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis. 2012;18(2):308–11.CrossRef Storms AD, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis. 2012;18(2):308–11.CrossRef
67.
go back to reference Hurt AC, et al. Community transmission of oseltamivir-resistant a(H1N1)pdm09 influenza. N Engl J Med. 2011;365(26):2541–2.CrossRef Hurt AC, et al. Community transmission of oseltamivir-resistant a(H1N1)pdm09 influenza. N Engl J Med. 2011;365(26):2541–2.CrossRef
68.
go back to reference Takashita E, et al. A community cluster of influenza a(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Euro Surveill. 2014;19(1).CrossRef Takashita E, et al. A community cluster of influenza a(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Euro Surveill. 2014;19(1).CrossRef
69.
go back to reference Chen LF, et al. Cluster of oseltamivir-resistant 2009 pandemic influenza a (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis. 2011;203(6):838–46.CrossRef Chen LF, et al. Cluster of oseltamivir-resistant 2009 pandemic influenza a (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis. 2011;203(6):838–46.CrossRef
70.
go back to reference Al-Tawfiq JA, Benkouiten S, Memish ZA. A systematic review of emerging respiratory viruses at the hajj and possible coinfection with Streptococcus pneumoniae. Travel Med Infect Dis. 2018. Al-Tawfiq JA, Benkouiten S, Memish ZA. A systematic review of emerging respiratory viruses at the hajj and possible coinfection with Streptococcus pneumoniae. Travel Med Infect Dis. 2018.
Metadata
Title
Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009–2017
Authors
Hebah A. Al Khatib
Asmaa A. Al Thani
Imed Gallouzi
Hadi M. Yassine
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3930-6

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue